Okay, let's tackle this question about the anti-inflammatory dose of aspirin. First, I need to recall the different doses of aspirin and their purposes. Aspirin is used for various purposes like pain relief, anti-inflammatory, antipyretic, and antiplatelet effects.

The core concept here is understanding the different therapeutic doses of aspirin and their corresponding mechanisms. For anti-inflammatory effects, higher doses are typically needed compared to low-dose antiplatelet therapy. So the question is testing knowledge on the dosage ranges for these different uses.

The correct answer is likely the higher dose, maybe around 650 mg to 1000 mg. The anti-inflammatory dose requires higher amounts to inhibit COX-1 and COX-2 enzymes effectively, which reduces prostaglandin synthesis, leading to decreased inflammation. In contrast, low-dose aspirin (like 75-100 mg) is used for its antiplatelet effect without significant anti-inflammatory action.

Now, the options aren't provided, but I need to think of common distractors. For example, options might include low-dose (75-100 mg), moderate for pain (325-650 mg), and high anti-inflammatory doses (1000 mg). Other options could be incorrect if they mention other drugs or incorrect ranges.

Clinical pearl: Remember that high doses are for inflammation, low for blood thinning. Never confuse aspirin with other NSAIDs in dosage. High-yield fact: Anti-inflammatory dose aspirin is higher than the dose used for cardiovascular protection.

**Core Concept**
Aspirin's anti-inflammatory effect depends on high-dose inhibition of cyclooxygenase (COX) enzymes, reducing prostaglandin synthesis. Pharmacokinetic differences between anti-inflammatory and antiplatelet doses are critical for clinical application.

**Why the Correct Answer is Right**
Anti-inflammatory doses of aspirin (650–1000 mg) achieve COX-1 and COX-2 inhibition in peripheral tissues, suppressing inflammation. This contrasts with the 75–100 mg/day antiplatelet regimen, which selectively irreversibly inhibits platelet COX-1 without significant systemic anti-inflammatory activity. The higher dose ensures sufficient plasma concentration to target both isoforms in inflamed tissues.

**Why Each Wrong Option is Incorrect**
**Option A:** 75–100 mg (antiplatelet dose) lacks anti-inflammatory efficacy due to insufficient COX-2 inhibition.
**Option B:** 325–650 mg (moderate analgesic dose) may partially inhibit COX-1 but fails to robustly suppress inflammation.
**Option D:** 1500 mg exceeds therapeutic range, increasing bleeding risk without proportional anti-inflammatory benefit.

**Clinical Pearl / High-Yield Fact**
Remember the "low-dose vs high-dose" dichotomy: aspirin <100 mg/day = antiplatelet; ≥650 mg = anti-inflammatory. Confusion with other NSAIDs (e.g., ibuprofen) is common—always confirm aspirin’s unique COX inhibition profile. **Correct Answer: C. 650–1000 mg**

✓ Correct Answer: C. 3 - 6 g/d